The CDMO Partner You Need.

Accelerating Complex Modalities from Development to Commercial

  • Purpose-built technology platforms to support your complex modalities
  • True end-to-end CDMO services that secure your supply chain
  • Speed to market, with efficient scale-up from clinical to commercialization
  • Quality-driven manufacturing with deep regulatory and compliance expertise

Seamless Supply with True End-to-End Support

One partner from drug substance to drug product

  • Fewer handovers between suppliers and project phases
  • Clear accountability across development and manufacturing activities
  • Better visibility and control from early development through commercial supply

Seamless Supply with True End-to-End Support

Why Choose CordenPharma?

As pharma innovators, your CDMO partner must bring the expertise, scale, and regulatory strength to support your programs at every stage. With decades of experience across six technology platforms, a global network expansion spanning three continents, and hundreds of years of combined facility expertise, we deliver true end-to-end services across the complete drug lifecycle, from drug substance to drug product. Our integrated capabilities and expanded capacity enable consistent execution, supporting development, clinical supply, and large-scale commercial manufacturing with confidence.

0

€ Million Net Sales

(in 2025)

0

cGMP Facilities Across Europe, North America & Asia

~ 0

Commercial Products Supported

> 0

Active Customers

0

Health Authorities Audits

(in 2025)

0

Customer Audits

(in 2025)

What You Need

True End-to-End Supply

Managing multiple CDMOs across development stages and technologies increases coordination effort, risk, and timelines. CordenPharma integrates development and manufacturing of complex modalities across APIs, Drug Products and Packaging at all scales, coordinated through a global delivery and project management model.

What this means for you:

  • Fewer handovers between suppliers and project phases
  • Clear accountability across development and manufacturing activities
  • Better visibility and control from early development through commercial supply

Learn more

How We Deliver

Find out more

Explore our CDMO capabilities across Technology Platforms

  • Peptides: End-to-end development and manufacturing of complex peptide APIs from early-stage to commercial supply.
  • Injectables: Clinical-to-commercial development and manufacturing of sterile injectable drug products, including aseptic fill and finish.
  • Small Molecule & Highly Potent Drug Substance: Scalable complex small molecules and highly potent compounds from early development through commercial supply.
  • Small Molecule & Highly Potent Drug Product: Flexible production of complex oral and sterile dosage forms, including highly potent compounds, from clinical to commercial supply.
  • Nanomedicine: Integrated development and manufacturing of lipid excipients and nanomedicines, including LNP formulation and scalable delivery systems.
  • Lipids: Specialized development and large-scale manufacturing of high-quality lipid excipients for advanced drug delivery systems and emerging nanomedicines.

Latest News

View all

Ready to start your CDMO project?

Want to find out more?